We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current PHVS market cap is 830.75M. The company's latest EPS is EUR -2.4710 and P/E is -8.24.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -35.48M | -21.08M | -26.42M | -26.2M | -27.18M |
Net Income | -39.2M | -22.63M | -21.9M | -23.6M | -32.75M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -8.01M | -25.01M | -54.14M | -86.71M | -96.91M |
Net Income | -8.03M | -25.99M | -42.73M | -76.33M | -100.88M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 167.73M | 147.8M | 189.74M | 169.34M | 398.69M |
Total Liabilities | 18.47M | 18.65M | 16.01M | 16.21M | 14.65M |
Total Equity | 149.26M | 129.15M | 173.73M | 153.13M | 384.05M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 20.6M | 101.1M | 212.09M | 167.73M | 398.69M |
Total Liabilities | 1.92M | 5.31M | 7.14M | 18.47M | 14.65M |
Total Equity | 18.67M | 95.79M | 204.95M | 149.26M | 384.05M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -67.16M | -25.21M | -45.69M | -69.24M | -93.05M |
Investing | -124k | -19k | -54k | -61k | -90k |
Financing | 8.65M | -57k | 63.79M | 63.66M | 325.39M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -6.68M | -21.5M | -44.6M | -67.16M | -93.05M |
Investing | -13k | -43k | -130k | -124k | -90k |
Financing | 21.63M | 101.2M | 143.67M | 8.65M | 325.39M |
Market Cap | 830.75M |
Price to Earnings Ratio | -8.24 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.12 |
Price to Book Ratio | 2.16 |
Dividend Yield | - |
Shares Outstanding | 40.82M |
Average Volume (1 week) | 36.36k |
Average Volume (1 Month) | 58.68k |
52 Week Change | 134.99% |
52 Week High | 33.00 |
52 Week Low | 8.20 |
Spread (Intraday) | 16.23 (66%) |
Company Name | Pharvaris NV |
Address |
emmy noetherweg 2 leiden, south holland 2333 CH |
Website | https://www.pharvaris.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions